Details for 2019732494

Up to date per 03.04.2026

Actions

Title / Product Name

ANTIPROLIFERATIVE VERBINDUNGEN UND BISPEZIFISCHER ANTIKÖRPER GEGEN BCMA UND CD3 ZUR KOMBINIERTEN ANWENDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019732494

EP Publication Number

3796912

E-Number

1547904

Language

PCT Number

US19033505

Publication Date

31.03.2021 A

15.02.2023 B1

Registration Date

15.02.2023

AT Publication Date

15.03.2023

Application Date

22.05.2019

Registration Number

Priorities

23.05.2018

201862675639 P

IPC

A61K 31/497 20000101AFI20220819BHEP

Maximum Duration of Protection

22.05.2039

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

PIERCE, Daniel, W.1500 Owens Street, Suite 500 San Francisco, CA 94158US

WONG, Lilly, L.10300 Campus Point Drive, Suite 100 San Diego, CA 92121US

Information about Fees